In mouse models of CDAA-induced NASH, activation of TLR9 can stimulate IL-1β expression in KCs, mediating steatohepatitis and hepatocyte apoptosis driven by lipid accumulation [137,138]. Here, TLR9 is linked to metabolic dysfunction-associated steatohepatitis.